drugset
drugset / Trial / NCT02757404

Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity

NCT02757404 ↗

Phase 4 Completed 59 enrolled Medy-Tox
RandomizedParallel-groupSingle-blindTreatment

Summary

Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity.

Timeline

Start
2016-05-30
Primary completion
2016-08-16
Completion
2016-08-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Meditoxin Protein / enzyme biologic — Other

Indications

No indication recorded.